Spermosens AB (STU:9R5) Additional Paid-In Capital : €0.00 Mil(As of Sep. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Spermosens AB Additional Paid-In Capital?

Spermosens AB's annual additional paid-in capital increased from Dec. 2021 (€3.02 Mil) to Dec. 2022 (€4.50 Mil) and increased from Dec. 2022 (€4.50 Mil) to Dec. 2023 (€5.87 Mil).

Spermosens AB Additional Paid-In Capital Historical Data

The historical data trend for Spermosens AB's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Spermosens AB Additional Paid-In Capital Chart

Spermosens AB Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

0.48

3.02

4.50

5.87

Spermosens AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Additional Paid-In Capital	Get a 7-Day Free Trial													-	5.87	-	-	-

Spermosens AB Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Spermosens AB Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Spermosens AB's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Spermosens AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Spermosens AB (STU:9R5) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

SPERM:Sweden

Address

Scheeletorget 1, Medicon Village, Lund, SWE, 223 81

Website

https://www.spermosens.com

Spermosens AB is developing a revolutionary platform technology for diagnosing male-factor infertility and directing to the right infertility treatment. It is a developer of medical device products for male infertility, individualizing In Vitro Fertilization (IVF) diagnostics and treatment creating a new standard for faster and safer IVF treatments.

Spermosens AB Headlines

No Headlines